Using opioids in general practice for chronic non-cancer pain: an overview of current evidence

David C Currow, Jane Phillips and Katherine Clark
Med J Aust 2016; 205 (7): . || doi: 10.5694/mja16.00618
Published online: 3 October 2016

The letter by Alderman and colleagues is a timely reminder of the continued importance of post-marketing surveillance, especially for medications with frequently encountered and well characterised harms. As outlined, such surveillance must include all medications, whether or not they are subsidised or sold over the counter, in order to account for drug–host and drug–drug interactions.

  • David C Currow1
  • Jane Phillips2
  • Katherine Clark3,4

  • 1 Flinders University, Adelaide, SA
  • 2 University of Technology Sydney, Sydney, NSW
  • 3 Calvary Mater Newcastle, Newcastle, NSW
  • 4 University of Newcastle, Newcastle, NSW


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.